Skip to main content

CITADEL ADVISORS LLC

Position in TYRA — Tyra Biosciences, Inc.

CIK 1423053 MIAMI, FL

Position in TYRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,889,124
+$8,299,458 QoQ
Shares Held
278,307
+1707.7% QoQ
Ownership
0.466%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 170 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TYRA Over Time

Shares Held

Position Value (USD)

Derivatives in TYRA

reported options exposure · as of Mar 31, 2026
CallValue
$559,180
CallShares
14,600
PutValue
$681,740
PutShares
17,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. TYRA ranks #105 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TYRA

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,889,124 278,307
2026-03-31 $681,740 17,800
2026-03-31 $589,666 15,396
2026-03-31 $559,180 14,600
2025-12-31 $328,625 12,500
2025-09-30 $328,765 23,500
2025-09-30 $1,556,989 111,293
2025-06-30 $2,068,421 216,136
2025-03-31 $132,060 14,200
2025-03-31 $895,422 96,282
2025-03-31 $50,220 5,400
2024-12-31 $52,820 3,800
2024-12-31 $772,659 55,587
2024-12-31 $83,400 6,000
2024-09-30 $507,816 21,600
2024-09-30 $25,861 1,100
2024-09-30 $563,111 23,952
2024-03-31 $60,680 3,700
2024-03-31 $9,840 600
2024-03-31 $275,339 16,789
2022-12-31 $203,049 26,717
2022-12-31 $7,600 1,000
2022-12-31 $31,160 4,100
2022-09-30 $357,041 40,619
2022-06-30 $535,141 74,845
2022-03-31 $837,906 78,309
2021-12-31 $1,101,863 78,313